ATE382055T1 - Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren - Google Patents

Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren

Info

Publication number
ATE382055T1
ATE382055T1 AT01920759T AT01920759T ATE382055T1 AT E382055 T1 ATE382055 T1 AT E382055T1 AT 01920759 T AT01920759 T AT 01920759T AT 01920759 T AT01920759 T AT 01920759T AT E382055 T1 ATE382055 T1 AT E382055T1
Authority
AT
Austria
Prior art keywords
wnt
nucleic acids
acids encoding
related polypeptides
polypeptides
Prior art date
Application number
AT01920759T
Other languages
English (en)
Inventor
Luca Rastelli
Diane Pennica
Original Assignee
Curagen Corp
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Genentech Inc filed Critical Curagen Corp
Application granted granted Critical
Publication of ATE382055T1 publication Critical patent/ATE382055T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01920759T 2000-03-22 2001-03-22 Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren ATE382055T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19125800P 2000-03-22 2000-03-22

Publications (1)

Publication Number Publication Date
ATE382055T1 true ATE382055T1 (de) 2008-01-15

Family

ID=38885296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01920759T ATE382055T1 (de) 2000-03-22 2001-03-22 Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren

Country Status (11)

Country Link
US (3) US20020098540A1 (de)
EP (1) EP1265914B1 (de)
JP (1) JP2003527849A (de)
AT (1) ATE382055T1 (de)
AU (2) AU4778101A (de)
CA (1) CA2404216A1 (de)
DE (1) DE60132075T2 (de)
DK (1) DK1265914T3 (de)
ES (1) ES2298226T3 (de)
PT (1) PT1265914E (de)
WO (1) WO2001070775A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114644D0 (en) * 2001-06-15 2001-08-08 Oxford Glycosciences Uk Ltd Protein
WO2003087163A1 (en) 2002-04-15 2003-10-23 Chugai Seiyaku Kabushiki Kaisha METHOD OF CONSTRUCTING scDb LIBRARY
US8337841B2 (en) 2003-01-21 2012-12-25 Chugai Seiyaku Kabushiki Kaisha Methods of screening for antibody light chains
JP4794301B2 (ja) 2003-06-11 2011-10-19 中外製薬株式会社 抗体の製造方法
EP1693386A4 (de) * 2003-11-04 2008-12-31 Chugai Pharmaceutical Co Ltd Verfahren zur herstellung von antikörpern
US20050251054A1 (en) * 2004-05-10 2005-11-10 Medpond, Llc Method and apparatus for measurement of autonomic nervous system function
JP5057967B2 (ja) 2005-03-31 2012-10-24 中外製薬株式会社 ｓｃ（Ｆｖ）２構造異性体
AU2006232287B2 (en) 2005-03-31 2011-10-06 Chugai Seiyaku Kabushiki Kaisha Methods for producing polypeptides by regulating polypeptide association
KR101367544B1 (ko) 2005-06-10 2014-02-26 추가이 세이야쿠 가부시키가이샤 메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
CA2611726C (en) 2005-06-10 2017-07-11 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical compositions containing sc(fv)2
EP2009101B1 (de) 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Antikörpermodifikationsverfahren für die aufreinigung eines bispezifischen antikörpers
US20110229877A1 (en) 2008-07-07 2011-09-22 Oxford Nanopore Technologies Limited Enzyme-pore constructs
EP2310534B1 (de) 2008-07-07 2018-09-05 Oxford Nanopore Technologies Limited Basennachweispore
GB0820927D0 (en) 2008-11-14 2008-12-24 Isis Innovation Method
KR20110125226A (ko) * 2009-01-30 2011-11-18 옥스포드 나노포어 테크놀로지즈 리미티드 혼성화 링커
EP2391732B1 (de) 2009-01-30 2015-05-27 Oxford Nanopore Technologies Limited Verfahren die adaptoren zur nukleinsaure constructen für transmembrane sequenzierung benutzen
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
KR101939420B1 (ko) 2011-02-11 2019-01-16 옥스포드 나노포어 테크놀로지즈 리미티드 돌연변이체 세공
JP6298404B2 (ja) 2011-07-25 2018-03-20 オックスフォード ナノポール テクノロジーズ リミテッド 膜貫通ポアを用いる二重鎖ポリヌクレオチド配列決定のためのヘアピンループ方法
KR102083695B1 (ko) 2012-04-10 2020-03-02 옥스포드 나노포어 테크놀로지즈 리미티드 돌연변이체 리세닌 기공
US11155860B2 (en) 2012-07-19 2021-10-26 Oxford Nanopore Technologies Ltd. SSB method
CA2901545C (en) 2013-03-08 2019-10-08 Oxford Nanopore Technologies Limited Use of spacer elements in a nucleic acid to control movement of a helicase
GB201314695D0 (en) 2013-08-16 2013-10-02 Oxford Nanopore Tech Ltd Method
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
ES2881306T3 (es) 2013-09-27 2021-11-29 Chugai Pharmaceutical Co Ltd Método para la producción de heteromultímeros de polipéptidos
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
EP3137490B1 (de) 2014-05-02 2021-01-27 Oxford Nanopore Technologies Limited Mutante poren
CA2959220A1 (en) 2014-09-01 2016-03-10 Vib Vzw Mutant csgg pores
EP3204511B1 (de) 2014-10-07 2021-07-28 Oxford Nanopore Technologies Limited Mutante poren
GB201418159D0 (en) 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
AU2016381992B2 (en) 2015-12-28 2024-01-04 Chugai Seiyaku Kabushiki Kaisha Method for promoting efficiency of purification of Fc region-containing polypeptide
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method
CN114457052B (zh) * 2021-09-17 2024-02-27 厦门大学 一种抗肿瘤的多肽组合物及其应用

Also Published As

Publication number Publication date
DE60132075T2 (de) 2009-03-12
WO2001070775A2 (en) 2001-09-27
WO2001070775A3 (en) 2002-01-10
DK1265914T3 (da) 2008-03-10
EP1265914A2 (de) 2002-12-18
US20050159373A1 (en) 2005-07-21
ES2298226T3 (es) 2008-05-16
EP1265914B1 (de) 2007-12-26
JP2003527849A (ja) 2003-09-24
DE60132075D1 (de) 2008-02-07
PT1265914E (pt) 2008-04-08
US20020098540A1 (en) 2002-07-25
US20080206252A1 (en) 2008-08-28
AU2001247781B2 (en) 2006-02-02
CA2404216A1 (en) 2001-09-27
AU2001247781C1 (en) 2006-08-17
AU4778101A (en) 2001-10-03

Similar Documents

Publication Publication Date Title
ATE382055T1 (de) Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE69838143D1 (de) Antimikrobielle peptide
GB9823897D0 (en) Immunotherapeutic methods and molecules
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
EP1117682A4 (de) Peptide
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
AU4945001A (en) Angiogenesis associated proteins, and nucleic acids encoding the same
WO2001098355A3 (en) Cgi-69 compositions and methods of use
ATE315646T1 (de) Leukocyten-aktivierender faktor
DE69936513D1 (de) Menschliche p51-gene und deren genprodukte
DE69831584T2 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
DE60037413D1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
ATE332373T1 (de) Menschlisches il-1 epsilon dna und polypeptide
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
WO2002072765A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002097036A3 (en) Compositions and methods for adipose abundant protein
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods
CO5400145A1 (es) Proteina asociada con enfermedad
WO2002068648A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof
WO2002079494A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002074976A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002061088A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1265914

Country of ref document: EP